KALA BIO INC (KALA) Stock Balance Sheet
NASDAQ:KALA - Nasdaq - US4831192020 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 54.20M | 50.90M | 70.50M | 92.10M | 77.30M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 76.30M | |||
| Receivables | 3.46M | 236.00K | 1.10M | 17.50M | 9.90M | |||
| Inventories | N/A | N/A | 0.00 | 8.60M | 5.20M | |||
| Other Current Assets | 1.20M | 1.74M | 14.40M | 6.10M | 2.70M | |||
| Total Current Assets | 58.85M | 52.87M | 85.90M | 124.40M | 171.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.48M | 2.78M | 400.00K | 4.00M | 31.00M | |||
| Other Non-Current Assets | 273.00K | 301.00K | 500.00K | 11.00M | 19.20M | |||
| Total Non-Current Assets | 2.75M | 3.08M | 900.00K | 15.00M | 50.20M | |||
| TOTAL ASSETS | 61.61M | 55.95M | 86.80M | 139.40M | 221.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.98M | N/A | 5.00M | N/A | N/A | |||
| Accrued Expenses | 4.28M | 6.35M | 8.90M | 21.70M | 20.50M | |||
| Accounts Payable | 665.00K | 919.00K | 2.80M | 4.90M | 1.70M | |||
| Other Current Liabilities | 2.26M | 1.07M | 8.90M | 10.80M | N/A | |||
| Total Current Liabilities | 19.19M | 8.35M | 25.70M | 37.40M | 22.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 22.83M | 34.19M | 37.90M | 78.90M | 72.20M | |||
| Other Non-Current Liabilities | 5.87M | 5.91M | 4.20M | 6.30M | 27.10M | |||
| Total Non-Current Liabilities | 28.70M | 40.10M | 42.10M | 85.20M | 99.40M | |||
| TOTAL LIABILITIES | 47.89M | 48.45M | 67.80M | 122.60M | 121.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -650.79M | -629.41M | -587.20M | -542.40M | -399.80M | |||
| Additional Paid In Capital | 664.51M | 636.91M | 606.20M | 559.10M | 499.70M | |||
| Common Shares | 5.00K | 3.00K | 0.00 | 100.00K | 100.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 4.60M | 2.76M | 1.70M | 1.30M | 1.20M | |||
| Tangible Book Value per Share | 2.98 | 2.72 | 11.18 | 12.92 | 83.33 | |||
| Total Shareholders' Equity | 13.72M | 7.50M | 19.00M | 16.80M | 100.00M | |||
| TOTAL LIABILITIES AND EQUITY | 61.61M | 55.95M | 86.80M | 139.40M | 221.60M | |||
| Statistics | ||||||||
| Debt/Equity | 1.66 | 4.56 | 1.99 | 4.70 | 0.72 | |||
| Current Ratio | 3.07 | 6.33 | 3.34 | 3.33 | 7.72 | |||
| Return On Assets (ROA) | -62.84% | -75.42% | -51.64% | -102.30% | -47.08% | |||
| Return On Equity (ROE) | -282.23% | -562.35% | -235.89% | -848.87% | -104.33% | |||
All data in USD , ROIC based on taxRate of 0.21